Gennex Laboratories Limited Stock

Equities

GENNEX6

INE509C01026

Pharmaceuticals

Market Closed - Bombay S.E. 06:26:58 2024-04-26 am EDT 5-day change 1st Jan Change
16.08 INR -1.17% Intraday chart for Gennex Laboratories Limited -0.56% -4.34%
Sales 2022 612M 7.35M Sales 2023 656M 7.87M Capitalization 1B 12.05M
Net income 2022 39M 468K Net income 2023 49M 588K EV / Sales 2022 1.6 x
Net Debt 2022 26.33M 316K Net Debt 2023 31.28M 375K EV / Sales 2023 1.58 x
P/E ratio 2022
24.3 x
P/E ratio 2023
16.7 x
Employees 118
Yield 2022 *
-
Yield 2023
-
Free-Float 65.75%
More Fundamentals * Assessed data
Dynamic Chart
Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Gennex Laboratories Limited Appoints Dr. S. Ch. Dharma Rao as Additional Director (Non- Executive - Non Independent Director) CI
Gennex Laboratories Limited Announces Resignation of Tiruvarur Muralidharan Gopalakrishnan as Whole Time Director CI
Gennex Laboratories Gets Good Manufacturing Practices Certificate from Indian Regulator MT
Gennex Laboratories Limited announced that it expects to receive INR 966.125 million in funding from Premier Fiscal Services Pvt Ltd CI
Gennex Laboratories Board to Consider Raising Funds Via Equity MT
Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Gennex Laboratories Gets Permission to Manufacture, Sell Fexofenadine, Minoxidil MT
Gennex Laboratories Limited Obtains Approval of Additional Products from Drug Control Administration, Government of Telangana CI
Gennex Laboratories Gets WHO-GMP Certification from Drug Control Administration, Government of Telangana MT
Gennex Laboratories Arm Gets Drug Manufacturing License MT
Gennex Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Gennex Laboratories Limited Appoints Dinesh Kumar Kejriwal as Company Secretary & Compliance Officer CI
Gennex Laboratories Limited completed the acquisition of 6.73% minority stake in Deccan Remedies Limited. CI
Gennex Laboratories Limited Approves the Acceptance of Resignation of Rajesh Vankadara as Company Secretary & Compliance Officer CI
More news
1 day-1.17%
1 week-0.56%
Current month+1.77%
1 month-0.50%
3 months-14.69%
6 months+58.11%
Current year-4.34%
More quotes
1 week
15.90
Extreme 15.9
17.60
1 month
15.00
Extreme 15
17.93
Current year
13.90
Extreme 13.9
21.89
1 year
5.75
Extreme 5.75
21.89
3 years
4.81
Extreme 4.81
21.89
5 years
1.32
Extreme 1.32
21.89
10 years
0.88
Extreme 0.88
21.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 37 12-05-17
Director of Finance/CFO - -
Compliance Officer 60 23-04-19
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 57 03-03-21
Chief Executive Officer 37 12-05-17
More insiders
Date Price Change Volume
24-04-26 16.08 -1.17% 679 693
24-04-25 16.27 -1.93% 450,012
24-04-24 16.59 +2.22% 832,207
24-04-23 16.23 -0.49% 315,675
24-04-22 16.31 +0.87% 433,935

Delayed Quote Bombay S.E., April 26, 2024 at 06:26 am EDT

More quotes
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing bulk drugs, intermediaries, and biotech products. The Company has a robust product portfolio spread over major product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. The Company operates through the Pharmaceutical Products (Bulk Drugs) segment. The Company's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/USP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Chlorphenesin IP/BP, which is anti-fungal, and Melitracen Hcl, which is an antidepressant. The Company has manufacturing facilities in India which cater to both domestic and international markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. GENNEX6 Stock